There are several risk behaviors presented by NIDU for acquiring HIV, such as polysubstance use, inconsistent use of condoms, sex work, and multiple sexual partners (8) (9) (10) . Studies have shown elevated prevalence of HIV among NIDU worldwide, ranging from 3.7% in México to 16 .0% in the United States of America (11) (12) (13) (14) (15) .
Access to HIV testing permits infected individuals to receive early treatment, thus increasing survival rates and reducing morbidity and mortality associated with the virus (16, 17) . Furthermore, the knowledge of serological status also contributes to reducing risk behaviors and viral transmission (17, 18) . The rate of HIV transmission is estimated to be 3.5 times greater among individuals who are unaware of their serologic status (19) . It is estimated that approximately 50% of people with HIV throughout the world are unaware of their serological status (20) . Low perception of risk, lack of knowledge, and the stigma associated with HIV represent significant barriers for performing tests (21) (22) (23) , contributing to these rates.
Studies have indicated some factors are associated with HIV testing, namely sociodemographic characteristics (24) (25) (26) , sexual risk behaviors, history of sexually transmitted infections (STI) (25, 27) , self-perceived HIV risk (28) , and knowing people living with HIV/AIDS (PLHA) and/or someone who had died from AIDS (24, 29, 30) .
These determinants must be taken into account when planning healthcare actions and broadening coverage of the testing for those most vulnerable, such as NIDU. Thus, the A c c e p t e d M a n u s c r i p t aim of this study was to estimate the prevalence and factors associated with lifetime HIV testing in NIDU.
Methods

Design, population and period of the study
This was a cross-sectional study conducted with NIDU at two reference clinics for the treatment of chemical dependency, located in a city in the state of Goiás, Central-West region of Brazil. The study institutions offer assistance for users of alcohol and illegal drugs (injection and non-injection), including outpatient treatment (medical appointments, support groups, etc.) and hospitalizations for the treatment of mental and behavioral disorders due to psychoactive substances, either free through the Brazilian National Health System (Sistema Único de Saúde) or privately. Data were collected from December 2014 to June 2015.
Inclusion and exclusion criteria
Individuals eighteen years or older, who, according to self-reports, had used illicit noninjection drugs during the month prior to being admitted and were hospitalized with a medical diagnosis of mental and behavioral disorders due to psychoactive substances (except alcohol and tobacco) according to the ICD-10 (31), verified from the medical records, were included in the study. Individuals who were in a state of sedation or apparent agitation prior to the interview, and injecting drug users were excluded.
Data collection procedure
After obtaining permission from the directors of the clinics, all of the eligible individuals were invited to take part in the study. For recruitment, the directors provided a daily list of individuals hospitalized in the institutions. Next, the participants were individually and anonymously invited by members of the study team.
After explanation of the aims, methods, benefits and potential risks of the study, the participants who signed the Informed Consent form were interviewed in a private setting, using a standardized instrument to gather information on sociodemographic characteristics, HIV testing, illicit drug use, sexual behavior, history of STI, and selfperceived HIV risk. In addition, individuals who had been previously tested at some point in their life also answered a series of questions on the reasons for testing and type, place, and results of the test.
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The questionnaire was constructed by the researchers and included variables derived from instruments previously validated in vulnerable populations (10, 11, 24, 26, 27, 30, (32) (33) (34) (35) (36) (37) (38) (39) and other potential factors associated with HIV testing. The interviews were conducted by members of the study team who were professional experts in mental health and had been previously trained.
Variables
Outcome variable
Lifetime HIV testing, obtained through of the question: "Have you ever been tested for HIV/AIDS?".
Predictor variables
The following predictor variables were considered: 
Data analysis
The data were analyzed using the Statistical Package for the Social Sciences (SPSS), version 22.0. Descriptive analysis was used to describe the sociodemographic characteristics of the participants. Prevalence of HIV testing patterns was estimated with a 95% confidence interval (95% CI). Factors associated with lifetime HIV testing were analyzed through multivariate logistic regression. First, bivariate analysis was conducted through simple logistic regression. Next, variables with p <.10 were included in the multivariate analysis. The potential confounders, age and gender, were controlled for in the multivariate model. Pearson's chi-squared test (χ 2 ) was used to verify differences between proportions for the categorical variables and Student's t-test for the continuous variables. Values of p <.05 were considered statistically significant.
Ethical aspects
The study was approved by the Research Ethics Committee of the Federal University of Goiás, Brazil, under authorization No. 926.819/2014. The investigation adhered to the guiding ethical principles for research involving human subjects in Brazil (41).
Results
Sociodemographic characteristics and drug use patterns
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All individuals admitted to the institutions during the study period were invited to participate in the study (n = 380). Of these, 15 refused to participate, 20 were sedated/agitated prior to the interview and 22 were injecting drug users, resulting in 323 NIDU investigated (85.0% of the total number of patients in the institutions).
Mean age of the participants was 32.4 years (SD + 11.3). The majority were male (83.0%), single (72.2%), and the most frequently self-declared skin color was brown/mulatto (59.3%). Participants reported using crack (75.9%), intranasal cocaine (47.2%), marijuana (51.5%), inhalants (26.5%), LSD (13.0%), ecstasy (12.7%), and non-injection heroine (3.7%), within the month prior to admission. 
HIV testing
Bivariate analysis
In the bivariate analysis, age, gender, crack use, marijuana use, history of STI, knowing PLHA and/or someone who had died from AIDS, and having received guidance on HIV prevention methods were associated with the outcome (p <.05). These variables, intranasal cocaine use (p =.05) and group sexual relations (p =.09) were included in the multivariable model (Table 2) . 
Multivariate analysis
Discussion
In Brazil, it is estimated that approximately 734.000 people live with HIV/AIDS (0.4% of the population) (42) . In the Central-West region, as well as the rest of the country, the epidemiology of HIV is concentrated in populations with high-risk behaviors, including illicit drug users (7, 42) . Access to HIV testing for NIDU is fairly challenging and complex, due to the marginalization and stigmatization of this group (18) . Thus, widening the coverage of HIV testing for this population is an important tool for the prevention and reduction of transmission among NIDU.
To our knowledge, this is the first study to assess the factors associated with HIV testing in NIDU in the Central-West Region of Brazil. In this study, the prevalence of HIV testing was 48.9%, higher than the rate estimated for the general Brazilian population (36.5%) (43) . This was possibly due to an increased self-perception of vulnerability and risk behaviors in these individuals, as the study sample was composed of subjects undergoing treatment for addiction. When compared to other illicit drug users in Brazil, the prevalence of HIV testing was similar the those estimated in the cities of Rio de Janeiro (State of Rio de Janeiro, Southeast region) (42.0%) (37), São Paulo (State of São Paulo, Southeast region) (55.9%) (10), and Goiânia (State of Goiás, Central-West region) (54.4%) (44) .
Sociodemographic factors, such as female gender and age, were associated with the outcome, which is in agreement with other studies (24, 26, 32, 45, 46) . Women present higher prevalence of HIV testing due to access through prenatal care services, whereas men have less access to health services (21, 47) . With regards to age, an increase in testing with increasing age was observed, suggesting greater exposure to risk situations with longer life. Furthermore, an association between HIV testing and increased age is Thus, efforts should be made to increase testing in young populations of NIDU.
The results showed an association between crack use and HIV testing. Crack users present high rates of risk behaviors, such sex work, multiple sexual partnerships,
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and inconsistent use of condoms (49) . In addition, studies have indicated a strong association between crack use and HIV infection (49, 50) . Thus, such multiple exposures to risk factors may explain this high rate of testing among crack users.
Having a history of STI was associated with the outcome, as has been observed in other studies (25, 27, 34) . The presence of STI increases the risk of contracting HIV (26) and also increases awareness of self-perceived risk (25) . In addition, some STI show symptoms, prompting engagement with healthcare services and thereby increasing the likelihood of the suggestion of a test by a healthcare provider. A medical diagnosis of STI can also lead health professionals to request an anti-HIV test (25) , increasing testing coverage in this subgroup.
In this study, knowing PLHA and/or someone who had died from AIDS was associated with HIV testing among NIDU, corroborating the results of other investigations (28, 30) . Individuals who received guidance on HIV/AIDS prevention methods were almost three times more likely to perform the test for HIV. Educational activities related to infection and safe sex can motivate individuals to perform the test, indicating that educational and health promotion strategies must be included when planning healthcare for drug users.
The present study showed that only 26.6% of the participants reported having access to the rapid test, indicating the need for this strategy to be broadened among in this population. The low prevalence of the use of rapid tests and testing is due to test limitations in public counseling and testing centers (51) . In Brazil, HIV testing is mainly offered in specialized centers, which promote access to free, confidential, anonymous and fast testing, followed by treatment in reference services in cases of positivity (51), this being scarce in private clinics, public substance abuse treatment clinics and primary health units. In this study, the rapid test was used more by individuals who reported performing the test in counseling and testing centers than by those who performed it in other health units (p = <.01) (data not shown). The use of the HIV rapid test should be a priority in the prevention of HIV infection among groups that are difficult to access (47), such as drug users. Therefore it is necessary to make rapid testing available at other sites, including substance abuse treatment clinics and primary health unit, aiming to expand test coverage among NIDU. Furthermore, 46.8% of the individuals reported performing the test in the private healthcare network, which highlights the need to widen free access to the test. Finally, the prevalence of self-reported HIV infection was 3.2% (95% CI:
A c c e p t e d M a n u s c r i p t 1.4-7.2%), similar to that estimated for NIDU in Argentina (14) , Luxembourg (13), Spain (12) and Mexico (11). However, it was lower than that found in the USA (15).
The current study presents some limitations. First, the cross-sectional nature of the investigation does not allow causal relationships to be established. Second, the sample consisted only of individuals in treatment, which prevents the generalization of the results to other NIDU. Third, the data were self-reported, which can be influenced by memory and response biases. Despite these limitations, the study aimed to estimate the prevalence and factors associated with HIV testing in NIDU, which can contribute to adherence strategies and increasing the coverage of testing among these individuals.
The results of this study have implications for future research and health promotion interventions. Efforts should concentrate on increasing the coverage of HIV testing in NIDU in order to achieve adequate test coverage (90% of the target population) (48) , especially considering those with lower testing rates, such as males, younger individuals and those with less access to STI prevention services. The results of this study can support public policies for epidemic control in NIDU by promoting a link between STI prevention services and addiction treatment services. New studies with illicit drug users are needed to evaluate the coverage of testing in this population and the factors that interfere with access to STI prevention services for NIDU.
In conclusion, the prevalence of lifetime HIV testing among the investigated NIDU was 48.6%, higher than that estimated for the general population in Brazil. Prior A c c e p t e d M a n u s c r i p t
